EUVIMEDEUVIMED entdecken
Crossref

A Blood-based DNA Methylation Signature for Non-invasive Diagnosis and Prediction of Clinical Outcomes in Patients with Glioblastoma Enrolled on the Phase II Randomized VERTU Trial

E.J. Vaios, C. Wimberly, H.W. Sim, E. Barnes, E.S. Koh, S. Yip, M. Hall, G. Herrgott, H. Noushmehr, K. Ayasoufi, K. Batich, D.M. Ashley und 8 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S243

DOI: 10.1016/j.ijrobp.2026.06.520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von E.J. Vaios und 19 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vaios, E., Wimberly, C., Sim, H., Barnes, E., Koh, E., Yip, S., Hall, M., Herrgott, G., Noushmehr, H., Ayasoufi, K., Batich, K., Ashley, D., Floyd, S., Shih, H., Sulman, E., Simes, J., Reitman, Z., Walsh, K., Hu, B., & Khasraw, M. (2026). A Blood-based DNA Methylation Signature for Non-invasive Diagnosis and Prediction of Clinical Outcomes in Patients with Glioblastoma Enrolled on the Phase II Randomized VERTU Trial. International Journal of Radiation Oncology*Biology*Physics, 126(1), S243. https://doi.org/10.1016/j.ijrobp.2026.06.520

Vancouver

Vaios E, Wimberly C, Sim H, Barnes E, Koh E, Yip S, et al. A Blood-based DNA Methylation Signature for Non-invasive Diagnosis and Prediction of Clinical Outcomes in Patients with Glioblastoma Enrolled on the Phase II Randomized VERTU Trial. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S243. doi:10.1016/j.ijrobp.2026.06.520

BibTeX
@article{Vaios2026,
  author = {Vaios, E.J. and Wimberly, C. and Sim, H.W. and Barnes, E. and Koh, E.S. and Yip, S. and Hall, M. and Herrgott, G. and Noushmehr, H. and Ayasoufi, K. and Batich, K. and Ashley, D.M. and Floyd, S.R. and Shih, H.A. and Sulman, E.P. and Simes, J. and Reitman, Z.J. and Walsh, K. and Hu, B. and Khasraw, M.},
  title = {A Blood-based DNA Methylation Signature for Non-invasive Diagnosis and Prediction of Clinical Outcomes in Patients with Glioblastoma Enrolled on the Phase II Randomized VERTU Trial},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {S243},
  doi = {10.1016/j.ijrobp.2026.06.520}
}
Kostenlos starten →